CompletedNot Applicable

L-carnitine and COH in PCOS Women Undergoing IVF/ICSI Cycles

Iran110 participantsStarted 2020-03-01

Plain-language summary

The aim of this study was to evaluate the effect of oral L-carnitine supplementation during controlled ovarian stimulation (COS) in patients with polycystic ovary syndrome (PCOS) in a double-blind randomized clinical trial. The eligible patients with PCOS diagnosis (on the basis of Rotterdam criteria) who referred to Royan Research Institute for IVF / ICSI treatment cycles will be evaluated.

Who can participate

Age range20 Years – 37 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Exclusion criteria

✕. Patients diagnosed with hyperprolactinemia, diabetes mellitus, epilepsy
✕. Patients treated with special diet, medication supplement (ovuboost), metformin before or during ovarian stimulation
✕. History of pelvic surgery on ovaries and uterus.
✕. Presence of submucosal and intramural fibroids larger than 5 cm or the presence of uterine polyps and congenital uterine malformations.
✕. The cause of severe male infertility (TESE, PESA).

What they're measuring

Occyte maturity rate

Timeframe: 24 hours post oocyte retrieval day

Trial details

NCT IDNCT04672720

SponsorRoyan Institute

Sponsor typeOTHER_GOV

Study typeINTERVENTIONAL

Primary completion2022-12-29

View on ClinicalTrials.gov More Polycystic Ovary Syndrome trials